Test Price
2,800 AEDโ Home Collection Available
CASQ2 Gene Catecholaminergic Polymorphic Ventricular Tachycardia Type 2 Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
โ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing. โ Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM. โ Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation. โ Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This advanced next-generation sequencing (NGS) test analyzes the CASQ2 gene for pathogenic variants causing catecholaminergic polymorphic ventricular tachycardia type 2 (CPVT2), an inherited cardiac arrhythmia triggered by physical activity or emotional stress. The test delivers comprehensive gene coverage with copy number analysis, enabling precise diagnosis and risk stratification for sudden cardiac arrest.
| Feature | Our NGS Test | Conventional Sanger |
|---|---|---|
| Methodology | NGS (Illumina-based) with CNV detection | Sanger sequencing (targeted) |
| Turnaround Time | 3โ4 Weeks | 4โ6 Weeks |
| Sensitivity | >99.9% for SNVs & indels | ~95% (gene-wide) |
| Price (AED) | 2800 | N/A (limited local availability) |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh | Consultant Medical Genetics | DHA Registration ID: 9294403: โThis test can provide life-saving clarity for families with a history of exercise-induced syncope or unexplained sudden death. A genetic diagnosis must always be correlated with clinical findings and never replace regular cardiology follow-up. Please do not discontinue any prescribed medications, especially beta-blockers, without direct consultation.โ
Advisory Protocols
Medication Warning: Do not discontinue prescribed medication without consulting your doctor.
- If you have had a recent cardiac event (<48 hours), postpone collection until medically stable.
- This test is not suitable for individuals lacking a documented family history or clear symptoms of CPVT without genetic counseling.
Safety Exclusion Criteria & Emergency Red Flags
- Patients experiencing current chest pain, palpitations with dizziness, or syncope should seek immediate emergency care prior to testing.
- Sudden loss of consciousness during exertion, erratic heart rate over 200 bpm, or family history of sudden death at a young age demand urgent cardiological evaluation before proceeding.
Patient FAQ & Clinical Guidance
1. What is the CASQ2 gene test and who should consider it?
The CASQ2 NGS test identifies mutations responsible for catecholaminergic polymorphic ventricular tachycardia type 2, providing definitive diagnosis for individuals with exercise-induced syncope or a family history of sudden cardiac death.
2. How is the test performed and what is the turnaround time?
A simple blood draw or buccal swab is collected by our ISO-certified phlebotomist, and results are delivered within 3 to 4 weeks using advanced NGS analysis.
3. Are there any prerequisites before taking this genetic test?
Yes, a pre-genetic counseling session is essential to create a family pedigree and explain the implications of the results. Please provide complete clinical history and avoid discontinuing any heart medications without your cardiologistโs advice.
UAE Regulatory & Data Privacy Adherence
Your genetic data is handled in compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical testing safety and patient consent adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. All laboratory procedures are DHA-licensed and ISO-accredited.
Clinical & Logistical Metadata
| Test Name | CASQ2 Gene Full Sequencing (CPVT2) |
| Price (AED) | 2800 |
| Turnaround Time | 3โ4 Weeks |
| Sample Type / Matrix | Peripheral whole blood or buccal swab (VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available) |
| Methodology Used | Next-Generation Sequencing (Illumina) with CNV detection |
| ICD-10-CM Code | I47.2, Z87.89 |
| LOINC Code | 82123-2 |
| DHA Facility License & Address | License No. 1143 | DNA Labs UAE, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians